Table 58:
Budget Impact Analysis Results, nVNS for Acute Treatment, Migrainea
| Scenario | Budget impact, $ millionb | |||||
|---|---|---|---|---|---|---|
| Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | Totalb | |
| Budget impactc | 71.56 | 146.17 | 222.96 | 301.20 | 381.62 | 1,123.52 |
| nVNS costs | 71.56 | 146.17 | 222.96 | 301.20 | 381.62 | 1,123.52 |
| Acute medication costs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preventive medication costs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Monitoring costs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Abbreviation: nVNS, noninvasive vagus nerve stimulation.
a
nVNS costs were calculated based on the cost of the device and the number of people who would use it. Due to limited information, we did not estimate the impact of nVNS on medication and monitoring costs.
b
In 2024 Canadian dollars.
c
Results may appear inexact due to rounding.